Modern multifocal leukoencephalopathy (PML) activated by JC virus (JCV) is normally a risk for natalizumab-treated multiple sclerosis (Master of science) individuals. to improved monitoring, avoidance and treatment of PML in natalizumab-treated sufferers. Writer Overview Modern multifocal leukoencephalopathy (PML) is normally a problem of treatment with natalizumab in sufferers with multiple sclerosis (Master of science) and… Continue reading Modern multifocal leukoencephalopathy (PML) activated by JC virus (JCV) is normally